Clinical Trials
85 trialsEvaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
National Institutes of Health Clinical Center (CC)
Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
National Institutes of Health Clinical Center (CC)
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Institutes of Health Clinical Center (CC)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
National Institutes of Health Clinical Center (CC)
OCTANE
University Health Network, Toronto
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
National Institutes of Health Clinical Center (CC)
LEPIDOPTERA
Janssen Research & Development, LLC
PAIR-LUNG
Universidade Nova de Lisboa
Biomarkers for Risk Stratification in Lung Cancer
University of California, San Francisco
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Hoffmann-La Roche
Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.
AstraZeneca
Association Between Screening Behaviors and Lung Cancer Spectrum
Fudan University
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
University of Colorado, Denver
COPD Care Pathway Among Patients With Cancer
Wake Forest University Health Sciences
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
Peking University People's Hospital
SCLC Tarlatamab Blood Collection
Duke University
NIMBLE
Herlev and Gentofte Hospital
ALINEAR
AstraZeneca
BASECAMP-1
A2 Biotherapeutics Inc.
LIGHT-NING
Bristol-Myers Squibb
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
AstraZeneca
DIASTAG
AstraZeneca
APART-LUNG
University Hospital Schleswig-Holstein
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
A Retrospective Analysis of Statin Use and Outcome After Thoracic Cancer Surgery
Vanderbilt University Medical Center
Mass Spectral Fingerprinting in Lung Cancer
University of Zurich
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Novartis
A Registry for People With Lung Cancer
Memorial Sloan Kettering Cancer Center
UmbREALung
AstraZeneca
CASCADE
AstraZeneca
DP-04
AstraZeneca
ANASTASIA
AstraZeneca
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
National Institutes of Health Clinical Center (CC)
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
National Institutes of Health Clinical Center (CC)
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
Pfizer
FDG Immun Comb
Centre Antoine Lacassagne
Circulating Tumor DNA Mutations and Methylation Status as Biomarkers for Early Detection of Lung Cancer in Patients With Suspicious Lung Nodules
The University of Hong Kong
AURORA
Bristol-Myers Squibb
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids
Guangzhou Institute of Respiratory Disease
Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
UNICANCER
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Mayo Clinic
TICP
Hospices Civils de Lyon
PASSAT
AstraZeneca
OSIREAL
AstraZeneca
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
Massachusetts General Hospital
MK-3475-U01
Merck Sharp & Dohme LLC